Home Journals About My LA Reviewers Authors News Submit
Username: Password:
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


 Yes, sign up now
 Sign up for general news too

Privacy Statement
 
 
 

Clinical Medicine: Therapeutics

Synopsis: An open access, peer reviewed electronic journal that covers therapeutics in human clinical medicine.


Indexing: 2 major databases.  Pubmed indexing for NIH-funded research.

Processing time: Decision in 2 weeks for 90% of papers.

 


Latest news:
Journal newsletter sent to subscribers in week 37, 2009. Follow link to see newsletter summary.  Register to receive newsletters.
RSS

NEWS

TWITTER
View factor:
Journal: 56520
Most read article: 1329
Editor in chief:
Garry Walsh
ISSN: 1179-1713


 
 
 


Pharmacotherapy of Chronic Hepatitis B in Adults: Focus on Tenofovir Disoproxil Fumarate

Authors: Mamta K. Jain, Cindy L. Zoellner and Kanan Garg
Publication Date: 17 Sep 2009
Clinical Medicine: Therapeutics 2009:1 1291-1305

Mamta K. Jain1, Cindy L. Zoellner2 and Kanan Garg3

1UT Southwestern Medical Center, Department of Internal Medicine, Dallas, Texas. 2Parkland Health and Hospital System, Dallas, Texas. 3The University of Texas School of Public Health, Dallas Regional Campus, Dallas, Texas, USA.

Abstract

Treatment for hepatitis B (HBV), a global disease affecting over 400 million persons, has changed over the past 15 years. Many of the current treatments are oral therapies which suppress HBV viral load and improve liver-related outcomes. However, differences exist in the currently available therapies both in terms of potency and resistance. The newest HBV nucleotide to be approved for the treatment of hepatitis B is tenofovir disoproxil fumarate that when phosphorylated to its active form leads to DNA chain termination. Tenofovir is active against human immunodeficiency virus (HIV) and was approved for its treatment in 2001. It is also active against HBV and was approved for its treatment in 2008. Tenofovir has emerged as an effective and potent therapy against lamivudine resistant strains as well as wild type HBV. Tenofovir resistance to HBV is rare. Long-term use of tenofovir has been associated with renal and bone marrow toxicity in some HIV-infected patients. To date, this is the only oral therapy which is both potent and does not lead to viral resistance in both treatment naïve and experienced patients. Further studies in HBV mono-infected persons are needed to evaluate long-term impact of tenofovir use.

Categories: Pharmacology , Virology


Post comment




No comments yet...Be the first to comment.

Bookmark this article

LINKEDIN FACEBOOK

Add to Mixx! MIXX YAHOO! BUZZ

PERMALINK DIGG


Sign up for free journal updates

How should we address you?
Your email address
 Yes, sign up now


Recently published in this journal

Pharmacotherapy Options in Cancer Treatment-Induced Bone Loss: Focus on Bisphosphonates
- 25/Sep/2009

Current Rational to Prescribe Tigecycline: Critical Analysis of the Evidence and Usage Algorithms by an Argentinean Experts Panel
- 25/Sep/2009

Infliximab: A Review of its Use in the Treatment of Crohn’s Disease
- 25/Sep/2009

Metformin: A Review of its Use in the Treatment of Type 2 Diabetes
- 25/Sep/2009

Pharmacotherapy of Chronic Obstructive Pulmonary Disease: Focus on Arformoterol Tartrate
- 23/Sep/2009

A Review of Sildenafil in the Treatment of Pediatric Pulmonary Arterial Hypertension
- 23/Sep/2009

Collaboration to Meet a Therapeutic Need: The Development of Nelarabine
- 18/Sep/2009

Good News from Aliskiren?
- 17/Sep/2009

Present and Prospective Pharmacotherapies in Pulmonary Arterial Hypertension
- 17/Sep/2009

Tigecycline in the Treatment of Community-Acquired Pneumonia
- 17/Sep/2009

Pharmacotherapy of Chronic Hepatitis B in Adults: Focus on Tenofovir Disoproxil Fumarate
- 17/Sep/2009

Safety and Efficacy of Didanosine Enteric-Coated Capsule in Patients with HIV-1 Infection
- 17/Sep/2009

Aliskiren for the Treatment of Hypertension: An Update
- 15/Sep/2009

Montelukast: Pharmacology, Safety, Tolerability and Efficacy
- 15/Sep/2009

Rosiglitazone Maleate and Metformin Hydrochloride in Fixed Combination: What Role in the Treatment of Type 2 Diabetes?
- 10/Sep/2009

Pharmacotherapy of Bone Loss in Postmenopausal Women: Focus on Denosumab
- 09/Sep/2009

Ropinirole in the Treatment of Restless Legs Syndrome
- 09/Sep/2009

Pegylated Liposomal Doxorubicin for Advanced Ovarian Cancer in Women who are Refractory to Both Platinum- and Paclitaxel-Based Chemotherapy Regimens
- 09/Sep/2009

Azacitidine: A Review of its Use in the Management of Myelodysplastic Syndromes
- 07/Sep/2009

A Review of the Prevention of Invasive Breast Cancer with Raloxifene in Postmenopausal Women
- 07/Sep/2009

Pharmacotherapy of Restless Legs Syndrome with Pramipexole
- 07/Sep/2009

Pharmacotherapy Update: Risperidone in the Treatment  of Schizophrenia
- 07/Sep/2009

Palonosetron Hydrochloride in the Treatment of Chemotherapy-Induced Nausea and Vomiting
- 03/Sep/2009

A Review of Raltegravir and its Use in HIV-1 Infection
- 03/Sep/2009

A Re-assessment of the Safety and Efficacy of Interleukin-2 for the Treatment of Renal Cell Carcinoma
- 31/Aug/2009

Reduction in Risk of Myocardial Infarction, Stroke, and Death from Cardiovascular Causes. Focus on Rampiril
- 31/Aug/2009

Cardiotoxicity of Oral Methadone as an Analgesic - Recommendations for Safe Use
- 31/Aug/2009

Safety and Efficacy of Doxycycline
- 27/Aug/2009

Present and Prospective Pharmacotherapy for the Management of Patients with Type 2 Diabetes
- 27/Aug/2009

Exudative Age-Related Macular Degeneration: Current Therapies and Potential Treatments
- 27/Aug/2009

Safety and Efficacy of Eplerenone in the Management of Essential Hypertension
- 25/Aug/2009

Antipsychotic Drug Treatment for Patients with Schizophrenia: Theoretical Background, Clinical Considerations and Patient Preferences
- 17/Aug/2009

Benefits of ACE Inhibitors in Diabetes
- 14/Aug/2009

Insomnia: A Review of the Use of Eszopiclone
- 12/Aug/2009

Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib
- 12/Aug/2009

Clopidogrel Bisulfate: A Review of its Use in the Management of Acute Coronary Syndrome
- 07/Aug/2009

A Review of Enteric-coated Mycophenolate Sodium  for Renal Transplant Immunosuppression
- 07/Aug/2009

Pharmacotherapy of Epilepsy: Focus on Levetiracetam
- 05/Aug/2009

Current and Prospective Pharmacotherapies in Gastroesophageal Reflux Disease
- 05/Aug/2009

Pharmacotherapy of Candida Infections with Echinocandins
- 04/Aug/2009

Management Options in Chronic Stable Angina Pectoris: Focus on Ranolazine
- 31/Jul/2009

Pharmacotherapy with Pamidronate Disodium of Osteolytic Bone Metastases of Breast Cancer, Osteolytic Lesions of Multiple Myeloma, and Paget’s Disease
- 30/Jul/2009

Pharmacotherapy of Hematologic Malignancies with Tipifarnib
- 29/Jul/2009

Zolmitriptan and the Triptan Era
- 22/Jul/2009

Pharmacotherapy of Complicated Urinary Tract and Intra-abdominal Infections with Doripenem
- 15/Jul/2009

Glimepiride-pioglitazone Hydrochloride in the Treatment  of Type 2 Diabetes
- 15/Jul/2009

Safety and Efficacy of the bi-Sulfydryl ACE-Inhibitor Zofenopril in the Management of Cardiovascular Disease
- 15/Jul/2009

Pregabalin and Fibromyalgia Syndrome: A Treatment Option
- 15/Jul/2009

Bevacizumab: Its Place in the Treatment of Advanced  Non-small Cell Lung Cancer
- 13/Jul/2009

Safety and Efficacy of Lamotrigine in Older Adults with Epilepsy and Co-Morbid Depressive Symptoms
- 09/Jul/2009

Management of Transfusional Chronic Iron Overload: Focus on Deferasirox
- 09/Jul/2009

Experience with Cinacalcet for Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Stage III and IV
- 09/Jul/2009

Tipranavir: A Review of its Use in Therapy of HIV Infection
- 09/Jul/2009

Single Sevikar®: Combination Therapy for the Treatment of Hypertension
- 01/Jul/2009

Safety and Efficacy of I(131) Tositumomab in the Treatment of non-Hodgkin’s Lymphoma
- 01/Jul/2009

Triptans in the Treatment of Migraine
- 01/Jul/2009

Treatment Options in Smoking Cessation: What Place  for Bupropion Sustained-Release?
- 30/Jun/2009

Tetrabenazine in Huntington’s Disease Chorea
- 29/Jun/2009

Pharmacokinetics of Lopinavir in the LPV/R-Meltrex Formulation Compared to the LPV/R-Soft Gelatine Capsule in HIV Infected Patients
- 29/Jun/2009

Pharmacotherapy Update: Hyoscine Butylbromide in the Treatment of Abdominal Spasms
- 23/Jun/2009

Pharmacotherapy Update: Quetiapine use in Bipolar Disorder - What does the evidence tell us?
- 19/Jun/2009

Emerging Therapies for the Treatment of Essential Tremor
- 17/Jun/2009

Safety and Efficacy of Panitumumab in the Treatment of Metastatic Colorectal Cancer
- 12/Jun/2009

Lapatinib in the Treatment of Breast Cancer
- 12/Jun/2009

Secondary Stroke Prevention, and the Role of Antiplatelet Therapies
- 11/Jun/2009

First-line Treatment of Metastatic Breast Cancer: Focus  on Bevacizumab
- 10/Jun/2009

A Review of Trastuzumab-Based Therapy in Patients  with HER2-positive Metastatic Breast Cancer
- 08/Jun/2009

Hormone Refractory Prostate Cancer: Focus on Sipuleucel-T
- 08/Jun/2009

Pharmacotherapy of Excessive Sleepiness: Focus on Armodafinil
- 28/May/2009

Safety and Efficacy of Ambrisentan in the Treatment of Pulmonary Arterial Hypertension
- 27/May/2009

Therapeutic Options in Multiple Myeloma: Focus on Bortezomib
- 26/May/2009

A Review of Nelarabine in the Treatment of T-cell Lymphoblastic Leukemia/Lymphoma
- 21/May/2009

A Review of Levofloxacin for the Treatment of Bacterial Infections
- 15/May/2009

Pharmacotherapy of HIV: Focus on Etravirine
- 15/May/2009

The Prevention of Respiratory Syncytial Virus Infection in Children: Focus on Palivizumab
- 14/May/2009

Safety and Efficacy Review of Doxycycline
- 14/May/2009

Pharmacotherapy Update: Fludarabine in the Treatment of Non-Hodgkin’s Lymphoma
- 11/May/2009

A Review of the Pharmacokinetics, Pharmacodynamics and Efficacy of Zolmitriptan in the Acute Abortive Treatment of Migraine
- 11/May/2009

Metastatic Bone Disease in Patients with Solid Tumors—Burden of Bone Disease and the Role of Zoledronic Acid
- 08/May/2009

Lanreotide Autogel® in the Treatment of Acromegaly
- 07/May/2009

Sorafenib in Hepatocellular Carcinoma
- 06/May/2009

Hypertension Management and End Organ Protection: Focus on Aliskiren
- 01/May/2009

Pharmacotherapy of Oral Mucositis with Palifermin
- 01/May/2009

The Rise and Fall of Rosiglitazone
- 30/Apr/2009

Pharmacotherapy of Systemic Sclerosis: focus on Bosentan
- 16/Apr/2009

Efficacy and safety of fixed-dose Lercanidipine-Enalapril for the treatment of hypertension
- 20/Apr/2009

Current Approaches to the Treatment of Gastrointestinal Infections: Focus on Nitazoxanide
- 20/Apr/2009

A Review of Pramlintide in the Management of Diabetes
- 19/Apr/2009

Safety and Efficacy of Pioglitazone/Metformin Combination Therapy in Treatment of Type 2 Diabetes: A Rationale for Earlier Use
- 17/Apr/2009

Pharmacotherapy Options in Atrial Fibrillation: Focus on Vernakalant
- 17/Apr/2009

Pharmacotherapy of Retinal Diseases with Ranibizumab
- 16/Apr/2009

Sitaxentan for the Oral Treatment of Pulmonary Arterial Hypertension: Benefits from Endothelin Receptor Subtype Selectivity?
- 16/Apr/2009

Pharmacotherapy of HIV: A Focus on Atazanavir/Ritonavir a Potent and Convenient Once Daily Ritonavir Boosted Protease-Inhibitor for HIV-1 Infected Adults
- 09/Apr/2009

Hypertension: Focus on Olmesartan Medoxomil
- 08/Apr/2009

Pharmacotherapy of Paget’s Disease of Bone: Focus on Zoledronic Acid
- 08/Apr/2009

A Review of Delayed-Release MMX Mesalamine: It’s Use in the Treatment of Ulcerative Colitis
- 07/Apr/2009

Raltegravir: Its use in the Treatment of HIV Infection
- 03/Apr/2009

Efficacy and Safety of Sitagliptin in the Treatment of Type 2 Diabetes
- 03/Apr/2009

Management of Asthma with ICS and LABAs: different treatment strategies
- 03/Apr/2009

Pharmacotherapy of Insomnia: Focus on Zolpidem Extended Release
- 01/Apr/2009



Related journals...